Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis

We herein report the case of a 57-year-old woman presenting with a biopsy-proven tumefactive demyelinating lesion as her first clinical event. Subsequently, she displayed a relapsing-remitting course with recurrence of large demyelinating lesions exceeding 2 cm in diameter rather than the small ovoi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Intern Med
Main Authors: Nakamura, Masataka, Itani, Kumi, Miyake, Kousuke, Kunieda, Takenobu, Kaneko, Satoshi, Kusaka, Hirofumi
Format: Artigo
Jezik:Inglês
Izdano: The Japanese Society of Internal Medicine 2017
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5337470/
https://ncbi.nlm.nih.gov/pubmed/28090055
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki